Long‑acting muscarinic antagonist and long‑acting β2‑agonist therapy to optimize chronic obstructive pulmonary disease prior to lung cancer surgery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long‑acting muscarinic antagonist and long‑acting β2‑agonist therapy to optimize chronic obstructive pulmonary disease prior to lung cancer surgery

Published:2018-03-26 Issue: Volume: Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:mol clin onc

Author:

Makino Takashi¹,Otsuka Hajime¹,Hata Yoshinobu¹,Koezuka Satoshi¹,Azuma Yoko¹,Isobe Kazutoshi²,Sugino Keishi²,Ebihara Satoru³,Homma Sakae²,Iyoda Akira¹

Affiliation:

1. Division of Chest Surgery, Toho University School of Medicine, Ota, Tokyo 143‑8541, Japan

2. Division of Respiratory Medicine, Toho University School of Medicine, Ota, Tokyo 143‑8541, Japan

3. Department of Rehabilitation Medicine, Toho University School of Medicine, Ota, Tokyo 143‑8541, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The dynamic pulmonary functional change after thoracoscopic lower lobe segmentectomy;Asian Cardiovascular and Thoracic Annals;2022-12-30

2. Preoperative inhalation therapy for patients with chronic obstructive pulmonary disease undergoing lung surgery: a retrospective study;Journal of Cardiothoracic Surgery;2022-11-24

3. From COPD to Lung Cancer: Mechanisms Linking, Diagnosis, Treatment, and Prognosis;International Journal of Chronic Obstructive Pulmonary Disease;2022-10

4. Impact of COPD Treatment on Survival in Patients with Advanced Non-Small Cell Lung Cancer;Journal of Clinical Medicine;2022-04-24

5. Impact of smoking status and chronic obstructive pulmonary disease on pulmonary complications post lung cancer surgery;PLOS ONE;2022-03-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3